203 related articles for article (PubMed ID: 36653508)
1. A Full Factorial Design to Optimize Aminexil Nano Lipid Formulation to Improve Skin Permeation and Efficacy Against Alopecia.
Makky AMA; S El-Leithy E; Hussein DG; Khattab A
AAPS PharmSciTech; 2023 Jan; 24(1):40. PubMed ID: 36653508
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
3. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
[TBL] [Abstract][Full Text] [Related]
4. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
[TBL] [Abstract][Full Text] [Related]
6. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
7. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.
Rapalli VK; Kaul V; Waghule T; Gorantla S; Sharma S; Roy A; Dubey SK; Singhvi G
Eur J Pharm Sci; 2020 Sep; 152():105438. PubMed ID: 32598913
[TBL] [Abstract][Full Text] [Related]
8. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
Khan S; Baboota S; Ali J; Narang RS; Narang JK
Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
[TBL] [Abstract][Full Text] [Related]
9. Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: a novel potential approach for the treatment of alopecia.
Yazdani-Arazi SN; Ghanbarzadeh S; Adibkia K; Kouhsoltani M; Hamishehkar H
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1379-1387. PubMed ID: 27797271
[TBL] [Abstract][Full Text] [Related]
10. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
Rajinikanth PS; Chellian J
Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
[TBL] [Abstract][Full Text] [Related]
12. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.
Madan JR; Khobaragade S; Dua K; Awasthi R
Dermatol Ther; 2020 May; 33(3):e13370. PubMed ID: 32250507
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
[TBL] [Abstract][Full Text] [Related]
14. Topical caffeine-loaded nanostructured lipid carriers for enhanced treatment of cellulite: A 3
Kassem AA; Asfour MH; Abd El-Alim SH; Khattab MA; Salama A
Int J Pharm; 2023 Aug; 643():123271. PubMed ID: 37499772
[TBL] [Abstract][Full Text] [Related]
15. Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity.
Vieira R; Severino P; Nalone LA; Souto SB; Silva AM; Lucarini M; Durazzo A; Santini A; Souto EB
Molecules; 2020 Feb; 25(3):. PubMed ID: 32041134
[TBL] [Abstract][Full Text] [Related]
16. Development and Evaluation of Astaxanthin as Nanostructure Lipid Carriers in Topical Delivery.
Geng Q; Zhao Y; Wang L; Xu L; Chen X; Han J
AAPS PharmSciTech; 2020 Nov; 21(8):318. PubMed ID: 33175290
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured Etodolac Carriers in Transdermal Gel: Optimization and Characterization.
Patil P; Shirkhedkar A
Pharm Nanotechnol; 2023 Jun; 11(3):276-293. PubMed ID: 36635925
[TBL] [Abstract][Full Text] [Related]
18. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
19. Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.
Kim MH; Kim KT; Sohn SY; Lee JY; Lee CH; Yang H; Lee BK; Lee KW; Kim DD
Int J Nanomedicine; 2019; 14():8509-8520. PubMed ID: 31749618
[TBL] [Abstract][Full Text] [Related]
20. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery.
Shrivastava N; Khan S; Baboota S; Ali J
Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
